NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered peptides from Anlv Biotechnology? Mail in a sample (US only) and let us test it.

Test my supply
+1 more ↓
70%
Finnrick rating
#291 of 457 ranked vendors
18 of 21 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Anlv Biotechnology's purity-focus record is strongest on GHK-Cu and Survodutide, where recent identity, purity, and fill results are clean but batch IDs are often thin. Tirzepatide shows recovery after an early purity miss yet has a large overfill, while Tesamorelin remains the weak spot from an early low-purity, underfilled result.

methodology →
vendor intelligence report
Vendor Intelligence Report: Anlv Biotechnology

Corporate records are thinner than the sales trail: a Hebei entity lead, a WhatsApp-linked representative, and a managed Alibaba Cloud domain still do not resolve ownership. The report maps retained precursor-catalog exposure and co-hosted infrastructure.

25 pages5 risk factors assessed2 Jul 2026
read the report
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%31 Aug 2025: 73%31 Aug 2025: 47%23 Oct 2025: 48%17 Nov 2025: 47%29 Dec 2025: 47%7 Jan 2026: 48%15 Jan 2026: 59%19 Jan 2026: 59%19 Jan 2026: 61%19 Jan 2026: 62%29 Jan 2026: 65%15 Feb 2026: 65%20 Feb 2026: 67%20 Feb 2026: 69%20 Feb 2026: 69%20 Feb 2026: 69%22 Feb 2026: 69%7 Mar 2026: 67%7 Mar 2026: 69%7 Mar 2026: 69%15 Sep 2026: 69%7 Oct 2026: current 70%73%59%70%Aug 25Oct 26
Free peptide testing

Ordered peptides from Anlv Biotechnology? Mail in a sample (US only) and let us test it.

Test my supply
Anlv Biotechnology test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
15 Sep 2026
Pass
GHK-Cu
lab nameView COA
7 Mar 2026
Pass
Tirzepatide
lab nameView COA
7 Mar 2026
Pass
Tesamorelin
lab nameView COA
7 Mar 2026
Pass
Cagrilintide
lab nameView COA
22 Feb 2026
Pass
GHK-Cu
lab nameView COA
20 Feb 2026
Pass
Tirzepatide
lab nameView COA
20 Feb 2026
Pass
Tirzepatide
lab nameView COA
20 Feb 2026
Pass
Tesamorelin
lab nameView COA
20 Feb 2026
Fail
Retatrutide
lab nameView COA
15 Feb 2026
Pass
GHK-Cu
lab nameView COA
1-10 of 21

About Anlv Biotechnology test results from Finnrick

Anlv Biotechnology is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 21 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Anlv Biotechnology peptides in this dataset are Cagrilintide (1 test), GHK-Cu (5 tests) and Retatrutide (1 test). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 21 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered peptides from Anlv Biotechnology? Mail in a sample (US only) and let us test it.

Test my supply